No connection

Search Results

NNOX vs SNWV

NNOX
Nano-X Imaging Ltd.
BEARISH
Price
$2.47
Market Cap
$171.9M
Sector
Healthcare
AI Confidence
85%
SNWV
SANUWAVE Health, Inc.
BEARISH
Price
$20.61
Market Cap
$177.1M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
NNOX
--
SNWV
50.27
Forward P/E
NNOX
-8.1
SNWV
-2061.0
P/B Ratio
NNOX
1.03
SNWV
109.63
P/S Ratio
NNOX
13.97
SNWV
4.02
EV/EBITDA
NNOX
-2.7
SNWV
25.13

Profitability

Gross Margin
NNOX
-98.04%
SNWV
77.11%
Operating Margin
NNOX
-412.97%
SNWV
16.66%
Profit Margin
NNOX
0.0%
SNWV
26.82%
ROE
NNOX
-34.75%
SNWV
--
ROA
NNOX
-20.04%
SNWV
12.07%

Growth

Revenue Growth
NNOX
13.7%
SNWV
26.8%
Earnings Growth
NNOX
--
SNWV
--

Financial Health

Debt/Equity
NNOX
0.05
SNWV
14.19
Current Ratio
NNOX
4.14
SNWV
1.38
Quick Ratio
NNOX
3.8
SNWV
0.97

Dividends

Dividend Yield
NNOX
--
SNWV
--
Payout Ratio
NNOX
0.0%
SNWV
0.0%

AI Verdict

NNOX BEARISH

NNOX presents a contradictory profile with a stable Piotroski F-Score of 4/9 and strong liquidity, yet catastrophic operational efficiency. While the balance sheet is clean with low debt and a high current ratio, the company suffers from a negative gross margin of -98.04% and a technical trend of 0/100. The massive disconnect between the current price and the analyst target of $7.40 suggests a highly speculative growth play rather than a value investment. Overall, the severe operational losses and long-term price collapse outweigh the short-term liquidity strengths.

Strengths
Very low Debt/Equity ratio (0.05)
Strong short-term liquidity with a Current Ratio of 4.14
Trading near book value (Price/Book 1.03)
Risks
Catastrophic Gross Margin (-98.04%) indicating unsustainable cost of goods sold
Severe Operating Margin (-412.97%) showing massive cash burn
Extreme long-term price depreciation (5Y Change: -92.8%)
SNWV BEARISH

SNWV exhibits severe fundamental weakness, highlighted by a weak Piotroski F-Score of 3/9 and an extreme valuation gap. The stock is trading at $20.61, which is astronomically higher than its Graham Number ($1.32) and Intrinsic Value ($2.87). While revenue growth is strong at 26.8%, the company is burdened by a dangerous Debt/Equity ratio of 14.19 and a Price/Book ratio of 109.63. Despite 'strong buy' analyst ratings, the combination of bearish insider selling and a negative forward P/E suggests a high risk of a significant correction.

Strengths
Strong gross margins of 77.11%
Consistent revenue growth (26.8% YoY and Q/Q)
Positive current profit margin of 26.82%
Risks
Extreme overvaluation with a Price/Book ratio of 109.63
Critical leverage levels with a Debt/Equity ratio of 14.19
Weak financial health indicated by a Piotroski F-Score of 3/9

Compare Another Pair

NNOX vs SNWV: Head-to-Head Comparison

This page compares Nano-X Imaging Ltd. (NNOX) and SANUWAVE Health, Inc. (SNWV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile